Background Raynaud's phenomenon (RP) can be the first manifestation of systemic sclerosis (SSc) or other connective tissue diseases (CTDs), often preceding an overt disease by years. It is not known if markers of endothelial damage are detectable in those RP patients who subsequently develop a CTD. Objectives We studied RP patients at their first evaluation to correlate the levels of endothelial markers with the subsequent development of an overt disease 36 months later. Methods Eighty-two patients with RP at their first evaluation were recruited. We measured plasma levels of tissue-type plasminogen activator (t-PA) and von Willebrand factor (vWF), two markers of endothelial damage, and interleukin-6 (IL-6), a pro-inflammatory cytokine. Thirty healthy subjects served as healthy controls. Results At baseline, 67 patients showed capillaroscopic normal pattern and 15 patients, of which 11 were very early SSc, had scleroderma pattern. Plasma levels of t-PA, vWF and IL-6 were higher in patients with capillaroscopic normal pattern (p=0.0001) than in normal controls and even much higher in patients with scleroderma pattern (p=0.0001). In patients with capillaroscopic normal pattern and RP of recent onset (<18 months), vWF plasma levels were higher when autoantibodies were present (p=0.020). After 36 months, among 48 RP patients with capillaroscopic normal pattern who remained in follow-up, 24 were diagnosed as primary and 24 as secondary RP. In secondary RP, basal levels of t-PA, IL-6 and particularly vWF were higher than in primary RP (p=0.005, p=0.004, p=0.0001 respectively) and normal controls (p=0.0001 for all). Conclusions Our findings indicate that markers of endothelial damage are elevated in RP patients who subsequently develop SSc or other CTDs, even in the absence of capillaroscopic abnormalities.

Early endothelial damage in patients with raynaud's phenomenon / R. Gualtierotti, F. Ingegnoli, T. Schioppo, S. Griffini, E. Grovetti, M. Borghi, M. Cugno, P. Meroni. - In: ANNALS OF THE RHEUMATIC DISEASES. - ISSN 0003-4967. - 76:Suppl. 2(2017), pp. SAT0655.1022-SAT0655.1022. ((Intervento presentato al convegno EULAR Annual European Congress of Rheumatology : 14th–17th June tenutosi a Madrid nel 2017 [10.1136/annrheumdis-2017-eular.5416].

Early endothelial damage in patients with raynaud's phenomenon

R. Gualtierotti
;
F. Ingegnoli
;
T. Schioppo
;
S. Griffini
;
M. Borghi
;
M. Cugno
;
2017

Abstract

Background Raynaud's phenomenon (RP) can be the first manifestation of systemic sclerosis (SSc) or other connective tissue diseases (CTDs), often preceding an overt disease by years. It is not known if markers of endothelial damage are detectable in those RP patients who subsequently develop a CTD. Objectives We studied RP patients at their first evaluation to correlate the levels of endothelial markers with the subsequent development of an overt disease 36 months later. Methods Eighty-two patients with RP at their first evaluation were recruited. We measured plasma levels of tissue-type plasminogen activator (t-PA) and von Willebrand factor (vWF), two markers of endothelial damage, and interleukin-6 (IL-6), a pro-inflammatory cytokine. Thirty healthy subjects served as healthy controls. Results At baseline, 67 patients showed capillaroscopic normal pattern and 15 patients, of which 11 were very early SSc, had scleroderma pattern. Plasma levels of t-PA, vWF and IL-6 were higher in patients with capillaroscopic normal pattern (p=0.0001) than in normal controls and even much higher in patients with scleroderma pattern (p=0.0001). In patients with capillaroscopic normal pattern and RP of recent onset (<18 months), vWF plasma levels were higher when autoantibodies were present (p=0.020). After 36 months, among 48 RP patients with capillaroscopic normal pattern who remained in follow-up, 24 were diagnosed as primary and 24 as secondary RP. In secondary RP, basal levels of t-PA, IL-6 and particularly vWF were higher than in primary RP (p=0.005, p=0.004, p=0.0001 respectively) and normal controls (p=0.0001 for all). Conclusions Our findings indicate that markers of endothelial damage are elevated in RP patients who subsequently develop SSc or other CTDs, even in the absence of capillaroscopic abnormalities.
Settore MED/16 - Reumatologia
Settore MED/09 - Medicina Interna
2017
Article (author)
File in questo prodotto:
File Dimensione Formato  
EarlyEndothelian_GualtierottiEtAlii_ARD_Bmj_2017.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 69.66 kB
Formato Adobe PDF
69.66 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/505631
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 0
social impact